|
The Comprehensive Cancer Center at Wake Forest University Baptist Medical Center
is one of seven sites in the world participating in a clinical trial evaluating
the effectiveness of an anti-cancer vaccine in reducing the risk of breast
cancer recurrence. The vaccines, composed of GP2 or AE 37 peptides of the
HER2\neu protein, a cancer protein found in 60 to 70 percent of breast
cancers, and GM-CSF, an FDA-approved drug that stimulates bone marrow to make
new blood cells.
more >> make
a gift >>
The Comprehensive Cancer Center at Wake Forest University Baptist Medical Center
is among an elite group of U.S. cancer centers designated by the National
Cancer Institute as comprehensive – indicating excellence in research, patient
care and education.
|